search

Active clinical trials for "Bacterial Infections"

Results 471-480 of 589

The Impact of Helicobacter Pylori Infection on Immune Regulation and Clinical Course in HIV Patients...

HIVBacterial Infection Due to Helicobacter Pylori (H. Pylori)

The main objective of the study is to investigate the impact of H. pylori infection on immune activation and clinical outcome in HIV patients. Other specific study objectives are: To investigate the effects of H. pylori infection on immune activation and the T-cell profile in HIV positive patients and compare those with HIV negative controls. To assess the influence of H. pylori infection on virological and immune parameters, and on clinical progression of HIV infection (WHO stage, opportunistic infections). To assess the prevalence of H. pylori infection among HIV patients in the Komfo Anokye Teaching Hospital. To assess the prevalence of gastrointestinal symptoms in HIV patients in Kumasi. To assess the association of H. pylori infection with gastrointestinal symptoms and pathology in HIV patients. To compare the clinical and immunological response to antiretroviral therapy and in HIV-patients with and without concomitant H. pylori infection.

Completed10 enrollment criteria

WEUKBRE5555: IMI PROTECT(Work Package 2): Liver Injury & Antibiotics

InfectionsBacterial

The studies described in this protocol are all performed within the framework of PROTECT (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium) Workpackage 2 (WP2) and Workgroup 1. The primary aim of these studies is to develop, test and disseminate methodological standards for the design, conduct and analysis of Pharmacoepidemiological (PE) studies applicable to different safety issues and using different data sources. To achieve this, results from PE studies on 5 key adverse events (AEs) performed in different databases will be evaluated. Therefore, emphasis will be on the methodological aspects of the studies in this protocol and not on the clinical consequences of the association under investigation. The standards to develop will contribute to decreasing the discrepancies in results from different studies in the future and increase the usefulness and reliability of these studies for benefit-risk assessment in the EU. We propose to assess the association between antibiotics use and idiopathic acute liver injury with different study designs (descriptive, cohort, nested case-control and case crossover) across different primary care databases and to compare the results between databases, across designs to evaluate the impact of design/database/population differences on the outcome of the studied association. Specific aims (in each database): To describe characteristics, clinical features, and risk factors for acute liver injury in patients exposed and unexposed to antibiotics. To estimate the overall risk of acute liver injury associated with antibiotics exposure (users and non-users) in each database To estimate the risk of acute liver injury associated with various antibiotics classes To estimate the risk of acute liver injury associated with specific individual antibiotics To assess the effect of dose and duration of use for specific individual antibiotics. To compare the results of a case-control study with the results of a retrospective cohort study and self-controlled case series study in the different databases The proposed studies will be collected in populations from the following databases: The General Practice Research Database [GPRD] (UK), Health Improvement Network [THIN] (UK), BIFAP [Base de datos Informatizada para estudios Farmacoepidemiologicos en Atencion Primaria] (Spain)- the Bavarian Claims Database (Germany), Mondriaan (Netherlands), and the National Databases of Denmark.

Completed4 enrollment criteria

Assessment of the Efficacy of FOSFOMYCIN in Patients With Bacterial Infection

Bacterial Infection

This project aims to assess the clinical and microbiological efficacy of fosfomycin(FOM) in patients with bacterial infection. Primary objective: • To assess clinical and microbiological efficacy of FOM in patients with bacterial infection. Secondary objectives: To determine the rate and severity of unexpected adverse events. To determine the mean duration of therapy with FOM in patients with bacterial infection. Study design: Multi-center, non-interventional study

Completed2 enrollment criteria

Burden of Antibiotic Resistance in Gram-Negative Infections in Dutch Hospitals

Infection Resistant to DrugsGram-Negative Bacterial Infection

This study aims to assess how large an additional disease burden and what extra costs are generated by antibiotic resistance in patients suffering from infections caused by gram-negative bacteria, such as Escherichia coli and Pseudomonas aeruginosa, in hospitals in the Netherlands.

Completed5 enrollment criteria

Epidemiology of Hospital Acquired Pneumonia

Respiratory Tract Infection Bacterial

This project aimed at analyzing and assessing of the early and late Hospital-Acquired Pneumonia(HAP) bacterial pathogens and their resistance to antimicrobial agents. The incidence of their resistance to antimicrobial agent is assessed. Included are patients hospitalized in the Intensive Care Departments of cooperated University hospitals, who developed early or late HAP. Bacterial pathogens and their resistance to antibiotics are identified using standard microbiological methods. The patient's mortality with respect to their initial antibiotic therapy is statistically analyzed.

Completed4 enrollment criteria

Trial to Reduce Antimicrobial Use In Nursing Home Residents With Alzheimer's Disease and Other Dementias...

DementiaInfection1 more

This is a 52-month study (8 months preparation; 36 months to conduct the trial; 8 months data analyses and manuscript preparation) of a cluster randomized controlled trial (RCT) of an intervention to improve infection management for suspected UTIs and LRIs among residents with advanced dementia (N=480; N=240/arm) living in NHs (N=24; N=12/arm). The NH is the unit of randomization as the intervention must be delivered at the facility level to avoid contamination and because this is how it would be employed in the real-world. Analyses will be at the patient level.

Completed18 enrollment criteria

Early-Onset Sepsis Surveillance Study

InfantNewborn9 more

In this observational study, the NICHD Neonatal Research Network (NRN) is conducting surveillance of all infants born at NRN centers to identify all newborns who are diagnosed with early-onset sepsis (EOS) and/or meningitis. The study will: establish current hospital-based rates of EOS among term and preterm infants in the era of intrapartum antibiotic prophylaxis; monitor the organisms associated with EOS and meningitis; compare asymptomatic and symptomatic infants by gestational age and pathogen; and monitor sepsis-associated mortality rates by pathogen group.

Completed2 enrollment criteria

Bioequivalence Between Two Tablet Formulations Of Doxycycline Carragenate

Bacterial Infection

The purpose of this protocol is to study if two different tablet formulations of doxycycline are bioequivalent to each other.

Completed5 enrollment criteria

Study Evaluation Tazocin Intervention

Bacterial Infections

This is an antibiotic intervention study to determine the value of using piperacillin/tazobactam in reducing the cases of ESBL producing E. coli or K. pneumoniae colonization and infection.

Completed3 enrollment criteria

Optimization Management Study of Community Urinary Tract Infections Spectrum

Urinary Tract InfectionsResistant Infection2 more

Urinary tract infections are the second most common community-acquired infections. Even if extended spectrum β-lactamase-producing Enterobacteriaceae (ESBLE) cause fewer urinary tract infections, their proportion is increasing. New recommendations were published by ANSM in 2015, with specific recommendations for infections due to ESBL-producing Enterobacteriaceae. In this study, we wanted to evaluate the effectiveness of a recall of the 2015 recommendations in the form of a table attached to the ECBU report, associated with hygiene recommendations. Methodology: This prospective, multi-center, non-interventional study was conducted in collaboration with the Labazur laboratory over two 2-month periods, one without modification of the laboratory's practices, the other with the addition of documents on the CBEU report. The primary endpoint was the adequacy of prescriptions to ANSM 2015 recommendations.

Completed7 enrollment criteria
1...474849...59

Need Help? Contact our team!


We'll reach out to this number within 24 hrs